Lucid Diagnostics Inc Receivables Turnover Ratio (LUCD), from the second quarter 2026 to the second quarter 2025 current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Lucid Diagnostics Inc   (NASDAQ: LUCD)
 

Lucid Diagnostics Inc Accounts Receivables Turnover Ratio from the second quarter 2026 to the second quarter 2025

Quarterly Results, Trends, Rankings, Statistics


Lucid Diagnostics Inc 's ability to collect accounts receivable sequentially worsen to 7.33, indicating more challenging environment then in the first quarter 2026, but still, it is a far cry from any concerns. Lucid Diagnostics Inc 's Accounts Receivable average collection period in the Jun 30 2026 quarter, has increased to 50 days, from 40 days, in the Mar 31 2026 quarter.

If we take a look into Healthcare sector 459 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Jun 30 2026 from 1296 to 3121.

What is Receivable Turnover Ratio?
What is Lucid Diagnostics Inc Selling?


What is Receivable Turnover Ratio?




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

LUCD Receivables Turnover Ratio (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Receivable Change 191.69 % 1029.51 % 1328.89 % 1310.26 % 133.13 %
Y / Y Revenue Change 26.74 % 51.69 % 25.65 % 3.33 % 19.16 %
Receivable Turnover Ratio (TTM) 7.33 9.11 11.57 17.1 33.67
LUCD's Total Ranking # 3121 # 1296 # 908 # 668 # 352
Accounts Receivable average collection period days 50 40 32 21 11
Seq. Receivable Change 57.91 % 7.15 % 16.91 % 47.45 % 511.48 %
Seq. Revenue Change 17.36 % -16.49 % 24.19 % 4.13 % 40.46 %


Receivable Turnover Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 165
Healthcare Sector # 460
Overall Market # 3121

Receivable Turnover Ratio Statistics
High Average Low
0.15 0.11 0.02
(Dec 31 2024)  





LUCD Company Profile • Back to LUCD Efficiency Comparisons • Compare LUCD Receivables Turnover Ratio to its Competitors

Financial Statements
Lucid Diagnostics Inc 's Accounts Receivable $ 1 Millions Visit LUCD's Balance sheet
Lucid Diagnostics Inc 's Sales TTM $ 5 Millions Visit LUCD's Income Statement
Sources of LUCD's Revenues Visit LUCD's Sales by Geography

Other Accounts Receivable Turnover Ratios
Medical Equipment & Supplies Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
LUCD's Receivable Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
LUCD's Growth Rates LUCD's Roa LUCD's Inventory Turnover Ratio LUCD's Dividend Comparisons
LUCD's Profitability Ratios LUCD's Roi LUCD's Asset Turnover Ratio LUCD's Dividend Growth
LUCD's Valuation Ratios LUCD's Roe LUCD's Financial Strength Ratios LUCD's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Jun 30 2026 Receivable at quarter ending Jun 30 2026
Corcept Therapeutics Inc  13.54 $ 830.813  Millions$ 61.352  Millions
Rosecliff Acquisition Corp I  13.43 $ 16.467  Millions$ 1.226  Millions
Precipio inc   13.25 $ 27.198  Millions$ 2.052  Millions
Chemed Corporation  12.94 $ 2,595.001  Millions$ 200.565  Millions
Qhslab Inc   12.77 $ 3.017  Millions$ 0.236  Millions
Nrc Health  12.72 $ 139.996  Millions$ 11.004  Millions
Mannkind Corporation  12.39 $ 393.630  Millions$ 31.773  Millions
Petvivo Holdings Inc   12.34 $ 1.182  Millions$ 0.096  Millions
Siga Technologies Inc  12.32 $ 53.659  Millions$ 4.356  Millions
Alpha Pro Tech Ltd   12.25 $ 62.204  Millions$ 5.077  Millions
Vivos Therapeutics Inc   12.21 $ 21.135  Millions$ 1.731  Millions
Milestone Scientific Inc   11.98 $ 8.855  Millions$ 0.739  Millions
Teladoc Health Inc   11.88 $ 2,489.480  Millions$ 209.556  Millions
Premier Air Charter Holdings Inc   11.72 $ 31.562  Millions$ 2.692  Millions
Catheter Precision Inc   11.62 $ 1.915  Millions$ 0.165  Millions
Icu Medical Inc  11.42 $ 2,159.998  Millions$ 189.166  Millions
National Healthcare Corp  11.40 $ 1,559.020  Millions$ 136.723  Millions
Picard Medical Inc   11.34 $ 5.983  Millions$ 0.528  Millions
Vaso Corporation  11.31 $ 80.220  Millions$ 7.094  Millions
Innoviva Inc   11.22 $ 420.630  Millions$ 37.491  Millions
Lifeloc Technologies Inc   11.19 $ 9.269  Millions$ 0.828  Millions
Veracyte Inc   11.07 $ 544.735  Millions$ 49.194  Millions
International Stem Cell Corporation  10.91 $ 9.514  Millions$ 0.872  Millions
Caredx Inc   10.81 $ 458.089  Millions$ 42.359  Millions
C4 Therapeutics Inc   10.65 $ 35.039  Millions$ 3.290  Millions
Radnet Inc   10.53 $ 2,268.932  Millions$ 215.450  Millions
Kymera Therapeutics Inc   10.50 $ 105.000  Millions$ 10.000  Millions
Irhythm Holdings Inc   10.42 $ 825.702  Millions$ 79.250  Millions
Integrated Biopharma Inc  10.38 $ 42.568  Millions$ 4.101  Millions
Viemed Healthcare Inc   10.36 $ 301.606  Millions$ 29.102  Millions

Date modified: 2026-10-05T11:03:41+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.